IFAM
TMO icon

Institutional & Family Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Institutional & Family Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$141K Buy
255
+85
+50% +$48.7K 0.02% 165
2024
Q1 		$98.8K Sell
170
-1
-0.6% -$561 0.02% 185
2023
Q4 		$90.8K Buy
171
+27
+19% +$13.1K 0.01% 198
2023
Q3 		$72.9K Buy
144
+7
+5% +$3.73K 0.01% 199
2023
Q2 		$71.5K Buy
137
+1
+0.7% +$540 0.01% 205
2023
Q1 		$78.4K Sell
136
-14
-9% -$7.89K 0.01% 190
2022
Q4 		$82.6K Sell
150
-20
-12% -$10.6K 0.01% 186
2022
Q3 		$86K Buy
170
+8
+5% +$4.48K 0.02% 181
2022
Q2 		$88K Sell
162
-19
-10% -$10.5K 0.02% 182
2022
Q1 		$107K Buy
181
+7
+4% +$4.02K 0.02% 185
2021
Q4 		$116K Sell
174
-86
-33% -$53.7K 0.02% 191
2021
Q3 		$149K Buy
260
+46
+21% +$25.2K 0.02% 204
2021
Q2 		$108K Buy
214
+4
+2% +$1.89K 0.02% 231
2021
Q1 		$96K Sell
210
-153
-42% -$73K 0.02% 275
2020
Q4 		$169K Sell
363
-8
-2% -$3.75K 0.04% 198
2020
Q3 		$164K Buy
371
+198
+114% +$81.8K 0.04% 189
2020
Q2 		$63K Buy
173
+6
+4% +$2.01K 0.01% 286
2020
Q1 		$47K Sell
167
-5
-3% -$1.58K 0.01% 284
2019
Q4 		$56K Sell
172
-20
-10% -$6.06K 0.01% 305
2019
Q3 		$56K Sell
192
-2
-1% -$573 0.01% 283
2019
Q2 		$57K Sell
194
-4
-2% -$1.1K 0.01% 299
2019
Q1 		$54K Hold
198
– – 0.01% 318
2018
Q4 		$44K Sell
198
-6
-3% -$1.41K 0.01% 337
2018
Q3 		$50K Sell
204
-2
-1% -$460 0.01% 352
2018
Q2 		$43K Hold
206
– – 0.01% 361
2018
Q1 		$43K Buy
+206
New +$43.2K 0.01% 344

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Institutional & Family Asset Management's TMO Position: Q2 2024 in Review

Institutional & Family Asset Management increased its Thermo Fisher Scientific (TMO) stake by 50% in Q2 2024, buying an estimated $48.7K and bringing the position to 255 shares worth $141K. The position accounts for 0.02% of the portfolio, ranked #165.

Institutional & Family Asset Management first reported a position in TMO in Q1 2018 and has held it in 26 quarters since. The position peaked at $169K in Q4 2020. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Institutional & Family Asset Management held 255 shares of Thermo Fisher Scientific worth $141K as of Q2 2024.
  • Institutional & Family Asset Management bought 85 Thermo Fisher Scientific shares in Q2 2024, an estimated $48.7K.
  • Thermo Fisher Scientific made up 0.02% of Institutional & Family Asset Management's portfolio in Q2 2024, its #165 holding.
  • Institutional & Family Asset Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 26 quarters since.
  • Institutional & Family Asset Management's Thermo Fisher Scientific position peaked at $169K in Q4 2020.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.